Related Experiment Video
Updated: Sep 30, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Dysregulated RNA polyadenylation contributes to metabolic impairment in non-alcoholic fatty liver disease
Andrew M Jobbins1,2, Nejc Haberman1,2, Natalia Artigas1,2
1MRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, UK.
Abstract:
Pre-mRNA processing is an essential mechanism for the generation of mature mRNA and the regulation of gene expression in eukaryotic cells. While defects in pre-mRNA processing have been implicated in a number of diseases their involvement in metabolic pathologies is still unclear. Here, we show that both alternative splicing and alternative polyadenylation, two major steps in pre-mRNA processing, are significantly altered in non-alcoholic fatty liver disease (NAFLD). Moreover, we find that Serine and Arginine Rich Splicing Factor 10 (SRSF10) binding is enriched adjacent to consensus polyadenylation motifs and its expression is significantly decreased in NAFLD, suggesting a role mediating pre-mRNA dysregulation in this condition. Consistently, inactivation of SRSF10 in mouse and human hepatocytes in vitro, and in mouse liver in vivo, was found to dysregulate polyadenylation of key metabolic genes such as peroxisome proliferator-activated receptor alpha (PPARA) and exacerbate diet-induced metabolic dysfunction. Collectively our work implicates dysregulated pre-mRNA polyadenylation in obesity-induced liver disease and uncovers a novel role for SRSF10 in this process.
Insights
Pre-mRNA processing alterations, particularly polyadenylation, are linked to non-alcoholic fatty liver disease (NAFLD). Decreased SRSF10 expression exacerbates metabolic dysfunction in NAFLD.
Area of Science:
- Molecular Biology
- Gene Regulation
- Metabolic Diseases
Background:
- Pre-mRNA processing is crucial for gene expression and mRNA maturation in eukaryotes.
- Defects in pre-mRNA processing are linked to diseases, but their role in metabolic pathologies remains unclear.
- Non-alcoholic fatty liver disease (NAFLD) is a growing metabolic concern with complex underlying mechanisms.
Purpose of the Study:
- To investigate the role of pre-mRNA processing, specifically alternative splicing and polyadenylation, in NAFLD.
- To identify key regulatory factors involved in pre-mRNA dysregulation in NAFLD.
- To explore the functional significance of SRSF10 in metabolic regulation and liver disease.
Main Methods:
- Analysis of alternative splicing and polyadenylation patterns in NAFLD samples.
- Assessment of Serine and Arginine Rich Splicing Factor 10 (SRSF10) binding and expression.
- Inactivation of SRSF10 in cellular and animal models of NAFLD.
- Evaluation of metabolic gene polyadenylation and metabolic dysfunction.
Main Results:
- Alternative splicing and polyadenylation are significantly altered in NAFLD.
- SRSF10 expression is decreased in NAFLD, with its binding sites near polyadenylation signals.
- SRSF10 inactivation dysregulates polyadenylation of metabolic genes like PPARA and worsens diet-induced metabolic dysfunction.
- NAFLD models show altered polyadenylation of key metabolic genes.
Conclusions:
- Dysregulated pre-mRNA polyadenylation is implicated in obesity-induced liver disease (NAFLD).
- SRSF10 plays a novel and critical role in mediating pre-mRNA polyadenylation in liver metabolism.
- Targeting SRSF10 or polyadenylation pathways may offer therapeutic strategies for NAFLD.
Related Concept Videos
RNA Editing
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nuclear Export of mRNA
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

